PATENT CLAIM ANALYSIS

Application Number: 16171940
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-05
Patent Classification: ["424", "468000"]

Abstract:
Disclosed are once-daily formulations containing tetracyclines, especially doxycycline. Such formulations are useful, for instance, for the treatment of collagenase destructive enzyme-dependent diseases, such as periodontal disease and acne, and acute and chronic inflammatory disease states, such as rosacea and arthritis.

Claim (Index 58):
The composition of  claim 52 , wherein the stabilizer is selected from antioxidation agents, buffers or acids.

Metadata:
- Claim Count in Document: 56.0
- Percentile: 97.0
- Lexical Diversity: 1.45455
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['12926932', '12926934', '12155676', '10819620', '13920538']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8326806395498695
- 35 USC 102 Novelty (BERT): 0.561038239193963
- Combined Prediction Score: 0.8055163995142788
- Mean Citation Score: 505.867768
- Max Citation Score: 513.33887
- Similarity Product: 341.0459049369783

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test